Phase II study of panitumumab with FOLFOX or FOLFIRI as 1st line treatment in patients with metastatic colorectal cancer in Japan.
Phase of Trial: Phase II
Latest Information Update: 21 Jan 2017
At a glance
- Drugs Panitumumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms PaFF-J
- 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium
- 01 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Aug 2013 Planned end date changed from 1 Apr 2014 to 1 Apr 2015 as reported by University Hospital Medical Information Network - Japan.